[Federal Register: March 6, 2001 (Volume 66, Number 44)]
[Notices]               
[Page 13544]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06mr01-108]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 99N-1168]

 
Relative Risk to Public Health From Foodborne Listeria 
Monocytogenes Among Selected Categories of Ready-to-Eat Foods; Draft 
Risk Assessment Document and Risk Management Action Plan; Public 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA), in cooperation with the 
Food Safety and Inspection Service (FSIS) of the U.S. Department of 
Agriculture (USDA), and the Centers for Disease Control and Prevention 
is announcing the following public meeting: Relative Risk to Public 
Health from Foodborne Listeria Monocytogenes Among Selected Categories 
of Ready-to-Eat Foods; Draft Risk Assessment Document and Risk 
Management Action Plan. The purpose of the public meeting is to receive 
comments on the technical aspects of a draft risk assessment on the 
relationship between foodborne Listeria monocytogenes and human health, 
and on a proposed risk management action plan for L. monocytogenes. A 
notice of availability of the draft risk assessment and the action plan 
was published in the Federal Register of January 19, 2001 (66 FR 5515).
    Date and Time: The meeting will be held on March 19, 2001, 8:30 
a.m. to 4 p.m.
    Location: The meeting will be held at the Hilton Hotel, 2399 
Jefferson Davis Hwy., Arlington, VA 22202.
    Contact: Catherine M. DeRoever, Center for Food Safety and Applied 
Nutrition (HFS-6), Food and Drug Administration, 200 C St. SW., 
Washington, DC 20204, 202-205-4251, FAX 202-205-4970, e-mail: 
cderoeve@cfsan.fda.gov.
    Registration and Requests for Oral Presentations: Send registration 
information (including name, title, firm name, address, telephone, and 
fax number), to the contact person by March 14, 2001. Interested 
persons may present data, information, or views orally or in writing, 
on the issues identified above. Written submissions must also be made 
to the contact person by March 14, 2001. Time allotted for each 
presentation may be limited. If you wish to make a formal oral 
presentation, you should notify the contact person before March 14, 
2001, and be prepared to provide a brief statement of the general 
nature of the evidence you wish to present.
    If you need special accommodations due to a disability, please 
contact Catherine M. DeRoever (address above) at least 7 days in 
advance.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page.

SUPPLEMENTARY INFORMATION: The U. S. Department of Health and Human 
Services and the USDA are seeking comments on the technical aspects of 
the draft risk assessment in the following areas: (1) The assumptions 
made, (2) the modeling technique, (3) the data used, and (4) the 
transparency of the draft risk assessment document. All public comments 
will be reviewed and evaluated, and the assessment will be modified, as 
appropriate. The agencies are also inviting comments on the risk 
management strategies as presented in the draft action plan.

    Dated: February 28, 2001.
Ann M Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-5379 Filed 3-1-01; 4:23 pm]
BILLING CODE 4160-01-S